- About us
Malaria research in social and economic studies
Mobilize Against Malaria (MAM)
Mobilize Against Malaria (MAM) was implemented between 2007 and 2011 by partners in Ghana, Kenya and Senegal. As Pfizer’s signature philanthropic program to reduce malaria morbidity and mortality, the program supported promising models for the effective delivery of Artemisinin-based Combination Therapy (ACT) through private, public and community sectors.
The pilot project demonstrated the viability of improving access to ACTs by training Licensed Chemical Sellers (LCS) in Ashanti Region, Ghana. It demonstrated sustainable approaches to building and maintaining the capacity of community-run health huts in Senegal, and tested the efficacy of healthworker training in Kenya.
Throughout 2012-13, a multidisciplinary team at LSHTM will continue to work with local evaluation partners to facilitate the synthesis of cross-cutting issues emerging from the research, of strategic importance in the development of regional and global policy agendas on the delivery of health services. Cross-cutting evaluation research will focus on contextual evaluation, implementation fidelity, methodological approaches, training efficacy and the development of an evaluation model across the three country settings.